Normal people can be protected from these damages by FERMT1 through activation of ERK pathway and inhibition of cyclin‐dependent kinase (CDK) activity while in KS patients, they accumulate and result in photosensitivity and high risk of SCC (48–50). Here, FERMT1 is linked to Kindler syndrome.